NOUGUES MAXIMO F 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Feb 14, 2023
Insider Transaction Report
Form 4
NOUGUES MAXIMO F
Chief Financial Officer
Transactions
- Award
Common Stock
2023-02-10+58,601→ 159,028 total - Award
Stock Option (Right to Buy)
2023-02-10+81,399→ 81,399 totalExercise: $4.39Exp: 2033-02-09→ Common Stock (81,399 underlying)
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2023, January 1, 2024, July 1, 2024 and January 1, 2025, subject to the Grantee's continued service with the Company through the applicable vesting date.
- [F2]Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2023, January 1, 2024, July 1, 2024 and January 1, 2025, subject to the Optionee's continued service with the Company through the applicable vesting date.